查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835450

生命科學設備市場按產品類型、應用和分銷管道分類－全球預測，2025-2032年

Life Science Instrumentation Market by Product Type, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生命科學設備市場將成長至 1,385.1 億美元，複合年成長率為 8.37%。

關鍵市場統計數據
基準年 2024 728億美元
預計年份：2025年 789.7億美元
預測年份 2032 1385.1億美元
複合年成長率 (%) 8.37%

對儀器現狀進行簡要概述，闡明其範圍、分析方法以及影響採購和實驗室現代化的關鍵因素。

生命科學儀器生態系統在技術創新、監管嚴格性和不斷變化的終端用戶需求三者交匯的背景下運作。本報告旨在將複雜的發展趨勢提煉成簡潔明了的概要，以幫助實驗室、儀器製造商、試劑供應和機構採購領域的領導者。報告重點關注實證數據，這些數據揭示了實驗室工作流程的轉變、終端用戶資本配置行為的變化以及近期監管政策調整對營運的影響。

圍繞設備性能、下游應用和分銷模式展開討論，有助於相關人員更好地確定投資和夥伴關係的優先順序。引言部分闡明了研究範圍和方法，概述了構成競爭優勢的關鍵維度：設備效能、資料整合、服務模式和監管合規性。在此基礎上，後續章節檢驗技術進步和政策動態如何重塑採購週期、研發流程以及對供應商提供硬體和綜合服務生態系統的期望。

自動化、軟體優先設計和服務導向的商業模式如何重新定義實驗室工作流程和採購優先順序的競爭優勢

生命科學儀器領域近期發生的變革性變化，是由自動化、運算分析和模組化硬體設計等領域的融合進步所驅動的。實驗室越來越重視能夠實現高通量處理並保持靈活性以適應特定檢測的平台。因此，那些整合軟體主導工作流程和開放資料架構的供應商，透過縮短端到端週轉時間和促進跨平台互通性，獲得了策略優勢。

同時，雲端原生分析和機器學習應用的日益成熟，使得資料生命週期管理和網路安全作為採購標準的重要性日益凸顯。這些功能不再是可有可無的加值服務，而是設備價值不可或缺的一部分，影響學術研究、臨床診斷和工業品管等領域的採購決策。此外，服務導向型商業模式也呈現出顯著趨勢，這類模式將安裝、驗證、預防性保養和遠距離診斷等服務打包在一起，旨在最大限度地減少儀器停機時間，並確保實驗結果的長期可重複性。綜上所述，這些變化有利於那些在工作流程最佳化、法規遵循支援和可擴展服務交付方面擁有成熟能力的供應商。

2025年美國關稅調整的影響將重塑供應鏈策略、整體擁有成本評估和供應商選擇標準。

美國宣布的2025年關稅調整為醫療器材製造商和醫療採購商的供應鏈規劃帶來了新的營運複雜性。這些調整不僅影響最終組裝的醫療器械，還影響各種關鍵零件和耗材，迫使採購團隊重新評估籌資策略和合約條款。因此，許多製造商正在重新評估其供應商基礎，加快對替代零件供應商的資格認證，並探索部分近岸外包，以降低關稅波動帶來的風險。

對買家而言，影響不僅限於單價，還延伸至總擁有成本 (TCO)、保固和售後服務物流。採購週期較長的金融機構優先考慮合約條款中關於關稅成本轉嫁的條款，並尋求提高零件來源的透明度。同時，擁有多元化製造地和靈活物流基礎設施的供應商更有能力應對關稅的影響，並保持價格競爭力。最終結果是，各方更加重視供應鏈韌性、基於情境的採購計畫以及包含風險分擔機制和前瞻性應急安排的供應商合作關係。

透過對設備類別、最終用途和通路進行細粒度細分分析，確定產品策略、服務模式和通路的優先順序。

產品細分揭示了不同設備類別的需求促進因素的差異，這對創新藍圖和售後服務具有獨特的意義。依產品類型，我們考察了細胞分析儀器、層析法系統、電泳系統、PCR 系統、定序儀和光譜儀。在細胞分析儀器中，細胞影像系統和流式細胞技術之間存在明顯的二元分類，二者對影像分析軟體和多參數資料處理的要求各不相同。層析法系統進一步分為氣相層析法和液相層析法，溶劑管理、色譜管壽命和檢測器相容性會影響採購決策和耗材夥伴關係。電泳系統分為毛細管電泳和凝膠電泳，其中毛細管電泳因其自動化和小型化的優勢而日益普及。 PCR 系統分為傳統 PCR、數位 PCR 和即時 PCR，反映了它們在靈敏度、定量能力以及臨床和研究應用中的監管認可度方面的差異。本文討論了定序儀器，包括次世代定序和桑格定序，二者在通量、讀取長度和單樣本成本等方面各有提案。光譜儀器包括紅外線光譜儀、質譜儀、核磁共振儀和紫外可見光光譜儀，凸顯了它們在服務、校準和耗材支援方面的不同需求。

基於應用領域的細分有助於了解最終用戶需求如何影響功能優先順序和採購速度。根據應用領域，設備評估涵蓋學術研究、臨床診斷、藥物發現與開發、環境檢測以及食品飲料檢測。在臨床診斷領域，基因檢測、感染疾病檢測和癌症診斷對驗證和可追溯性有著嚴格的要求，因此供應商提供的完善文件和法規支援至關重要。環境檢測分為空氣品質檢測、土壤檢測和水質檢測，分散式檢測專案更重視設備的現場部署性和堅固耐用的設計。食品飲料檢測分為營養分析、病原體檢測和品質保證，快速的周轉時間和符合行業標準是重中之重。

從分銷管道的觀點，我們可以揭示影響產品普及速度和售後市場經濟的商業動態。基於分銷通路，我們檢驗了直銷、分銷商、經銷商和線上通路的市場覆蓋範圍。對於需要現場檢驗的複雜高價值設備，直銷關係往往佔據主導地位；而經銷商和經銷商在拓展耗材、配件和較為簡單的平台銷售範圍方面發揮著至關重要的作用。線上管道日益促進小額交易、備件購買和軟體授權續訂，從而對數位自助服務和嵌入式技術內容提出了新的期望。整合這些細分視角，可以為設計符合不同終端使用者需求的產品藍圖、支援服務和通路策略奠定精細的基礎。

區域動態分析，闡述美洲、歐洲、中東和非洲以及亞太地區的採用模式、監管複雜性以及配套基礎設施需求

區域動態持續影響生命科學儀器的發展時間表、監管預期和投資重點。美洲地區對高通量平台和整合資料解決方案的需求持續強勁，並且仍然是早期採用者研究和臨床實驗室的中心。該地區的政策對話和報銷框架也強調檢驗的性能和服務可靠性，鼓勵供應商加強其本地支持基礎設施和學術夥伴關係。

歐洲、中東和非洲正經歷著管理體制和採購行為不斷演變的複雜局面。在某些次區域，統一的標準推動了跨境採購；而在另一些次區域，本地需求則驅動著對成本敏感且性能可靠的設備的需求。供應商通常會調整其商業模式，以適應不同的採購週期和公共部門的合約規則。亞太地區在研究和臨床市場均呈現出快速的產能擴張，大量的公共和私人投資推動了對可擴展平台和自動化解決方案的需求。該地區的製造商正在努力平衡全球產品標準、本地支援能力和策略夥伴關係，這種策略需要將全球研發投資與在地化最佳化的商業和服務佈局相結合。

硬體巨頭與敏捷挑戰者之間的競爭動態，雙方競相透過軟體生態系統、差異化服務和策略聯盟來獲取價值。

計量領域的競爭格局正在發生變化，傳統硬體領導企業與注重軟體、服務和耗材生態系統的敏捷型參與企業之間的競爭日益激烈。儘管現有企業憑藉其規模、多年累積的檢驗經驗和廣泛的服務網路來維護裝置量客戶群，但它們面臨的挑戰往往在於如何透過創新速度、模組化和以數位化為先導的用戶體驗來展開競爭。為了整合互補優勢，例如硬體工程和雲端分析，或試劑專業知識和現場服務基礎設施，企業之間建立夥伴關係和非稀釋性合作的現像日益普遍。

策略差異化在售後市場中屢見不鮮。延長保固期、遠距離診斷和以結果為導向的服務合約能夠提高客戶維繫並創造新的經常性收入來源。圍繞檢測相容性、校準程序和資料處理演算法的智慧財產權在建立競爭壁壘方面也發揮關鍵作用。此外，併購、選擇性授權和OEM協議不斷重塑競爭格局，使企業能夠進入新的應用領域並加速地理擴張，同時降低自主研發所需的時間和成本。

為專注於模組化產品設計、強大的服務組合、富有韌性的供應鏈和通路最佳化的領導者提供切實可行的策略和戰術性建議

行業領導者應優先採取一系列戰術性和戰略舉措，以鞏固市場地位並在儀器的整個生命週期內獲取價值。首先，透過投資模組化產品架構和開放資料介面，並加快與實驗室資訊管理系統和第三方分析系統的整合，降低客戶轉換成本。其次，透過結合預防性保養、遠距離診斷和基於績效的契約，增強服務組合，減少關鍵應用的停機時間，並創造持續的收入來源。第三，透過多源採購、區域製造夥伴關係和組件標準化，實現供應鏈多元化，從而降低關稅和物流風險，同時更快地回應需求波動。

同時，商業團隊應最佳化通路策略，在複雜設備銷售中平衡直接銷售與授權經銷商銷售耗材和配件，並加強售後市場銷售的數位化管道。投資於監管和臨床支援能力有望在臨床診斷和藥物研發應用領域獲得回報，因為驗證文件和對監管問題的快速反應是關鍵的採購促進因素。最後，應加強與學術中心和終端用戶的夥伴關係，共同開發用例檢驗，以展示真實世界的結果，並加速同行機構的採用。將這些建議整合到一個藍圖中，將有助於研發、營運和商業職能圍繞優先考慮的價值促進因素協同運作。

結合相關人員訪談、技術綜合和情境分析的嚴謹混合調查方法，為設備相關人員提供可靠且以決策為導向的見解。

本執行摘要所依據的研究結合了主要相關利益者參與、二手文獻綜合和結構化定性分析，以確保得出可靠且與決策相關的結論。主要研究包括對科研、臨床和工業終端用戶的實驗室主任、採購負責人和技術經理進行訪談，並輔以與設備供應商的產品經理和供應鏈負責人的對話。這些對話有助於評估採購標準、服務期望以及近期政策變化對營運的影響。

二級資訊來源包括同行評審文獻、監管指導文件和製造商的技術規範，用於驗證技術聲明並檢驗性能特徵。分析方法包括主題編碼，用於識別影響產品採用的常見促進因素和阻礙因素；以及情境分析，用於探討關稅和供應鏈變數如何影響採購行為。品質保證步驟包括將訪談結果與技術文件進行交叉檢驗，以及與專家進行多次迭代審查，以完善解釋。這種混合方法既能提供細緻的見解，又能確保假設和資料來源的透明度。

強調模組化、資料互通性和服務主導夥伴關係關係的策略要務的匯聚指南採購和產品開發決策。

總之，生命科學設備領域正經歷著一場由自動化、以資料為中心的工作流程和服務型商業模式整合所驅動的關鍵性變革。這些因素正在重塑人們對產品開發、售後支援和通路策略的預期，同時政策變革和關稅趨勢也對供應鏈韌性提出了新的要求。相關人員能夠使其產品藍圖與軟體互通性保持一致、投資於全面的服務提案並實現供應鏈多元化的利害關係人，將更有能力應對短期衝擊並獲得長期價值。

展望未來，領導者應將設備採購視為一項策略合作，而不僅僅是資本投資決策，該夥伴關係涵蓋檢驗支援、資料管理和全生命週期維護。透過採用模組化、開放標準和協作檢驗方法，供應商和採購方都能加快設備應用，減少營運摩擦，並提高研究和臨床環境中的可重複性。本文提出的綜合分析為這類決策提供了一個實用的框架，使決策能夠集中精力，並兼顧技術要求和商業性現實。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的影像分析平台整合到您的高內涵顯微鏡工作流程中
  • 引進台式次世代定序儀，實現臨床實驗室的快速基因組分析
  • 建構單細胞多組體學系統，用於同時分析轉錄組和蛋白質組。
  • 開發用於高通量藥物篩檢應用的微流體實驗室晶片裝置
  • 將數位PCR技術應用於診斷中罕見基因突變的精確定量分析
  • 利用自動化液體處理機器人技術加快樣品製備速度並提高檢測結果的重複性
  • 推出整合遞送和即時監測模組的基於 CRISPR 的基因編輯工作站
  • 整合了雲端基礎資料管理平台，具備即時遠端設備監控功能
  • 高解析度質譜技術的進步增強了蛋白質結構解析
  • 實施基於物聯網的預測性維護系統，以最大限度地減少設備停機時間和成本。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生命科學設備市場（依產品類型分類）

  • 細胞分析設備
    • 細胞成像系統
    • 流式細胞技術
  • 層析法系統
    • 氣相層析法
    • 液相層析法
  • 電泳系統
    • 毛細管電泳
    • 凝膠電泳
  • PCR系統
    • 常規PCR
    • 數位PCR
    • 即時PCR
  • 定序設備
    • 次世代定序
    • 桑格定序
  • 光譜分析設備
    • 紅外線光譜
    • 質譜分析
    • 核磁共振方法
    • 紫外-可見光譜

第9章：生命科學設備市場（依應用領域分類）

  • 學術研究
  • 臨床診斷
    • 基因檢測
    • 感染疾病診斷
    • 腫瘤診斷
  • 藥物發現與開發
  • 環境檢查
    • 空氣品質檢測
    • 土壤檢測
    • 水質檢測
  • 食品和飲料檢查
    • 營養分析
    • 病原體檢測
    • 品質保證

第10章：生命科學設備市場（依通路分類）

  • 直銷
  • 分銷商和經銷商
  • 線上管道

第11章：生命科學設備市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：生命科學設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：各國生命科學設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Bruker Corporation
    • Eppendorf SE
    • Hitachi, Ltd.
    • Horiba, Ltd.
    • Merck KGaA
    • PerkinElmer, Inc.
    • Sartorius AG
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: MRR-43470FC608CD

The Life Science Instrumentation Market is projected to grow by USD 138.51 billion at a CAGR of 8.37% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 72.80 billion
Estimated Year [2025] USD 78.97 billion
Forecast Year [2032] USD 138.51 billion
CAGR (%) 8.37%

Concise orientation to the instrumentation landscape that clarifies scope, analytical approach, and the key vectors shaping procurement and laboratory modernization

The life science instrumentation ecosystem operates at the convergence of technological innovation, regulatory rigor, and evolving end-user demands. This report distills complex developments into a concise executive narrative designed to support leaders in laboratories, instrument manufacturing, reagent supply, and institutional procurement. Throughout the document, emphasis is placed on empirical signals that indicate shifts in laboratory workflows, changes in capital allocation behavior among end users, and the operational implications of recent regulatory clarifications.

By framing discussions around instrument capability, downstream applications, and distribution models, stakeholders can better prioritize investments and partnerships. The introduction clarifies scope and methodology while outlining the critical dimensions that define competitive advantage: instrument performance, data integration, service models, and regulatory alignment. With these anchors, the following sections examine how technological advances and policy dynamics are reshaping procurement cycles, research pipelines, and the expectations placed on suppliers to deliver both hardware and comprehensive service ecosystems.

How automation, software-first design, and service-oriented commercial models are redefining competitive advantage across laboratory workflows and procurement priorities

Recent transformative shifts in life science instrumentation are being driven by convergent advances in automation, computational analytics, and modular hardware design. Laboratories are increasingly prioritizing platforms that enable high-throughput processing while preserving flexibility for specialized assays. As a result, vendors who integrate software-driven workflows and open data architectures are gaining strategic advantage by reducing end-to-end turnaround times and easing cross-platform interoperability.

Concurrently, the maturation of cloud-native analytics and machine learning applications is elevating the importance of data lifecycle management and cybersecurity as procurement criteria. These capabilities are now intrinsic to instrument value rather than optional add-ons, influencing procurement discussions across academic research, clinical diagnostics, and industrial quality control. Additionally, there is a pronounced shift toward service-oriented commercial models that bundle installation, validation, preventive maintenance, and remote diagnostics to minimize instrument downtime and protect long-term experimental reproducibility. Taken together, these shifts favor suppliers that can demonstrate proven outcomes in workflow optimization, regulatory compliance support, and scalable service delivery.

Implications of United States tariff adjustments for 2025 that are reshaping supply chain strategies, total cost of ownership assessments, and vendor selection criteria

Tariff changes announced for 2025 in the United States have injected a new layer of operational complexity into supply chain planning for instrument manufacturers and institutional buyers. The adjustments affect not only final assembled devices but also a range of critical components and consumables, prompting procurement teams to reassess sourcing strategies and contract terms. In response, many manufacturers are reevaluating their supplier base, accelerating qualification of alternative component suppliers, and exploring partial nearshoring to mitigate exposure to tariff volatility.

For purchasers, the implications extend beyond unit price into total cost of ownership considerations, warranty provisioning, and service logistics. Institutions with long procurement cycles are prioritizing contractual clauses that address tariff-induced cost pass-throughs and are seeking greater transparency around component origin. Meanwhile, vendors with diversified manufacturing footprints and flexible logistics infrastructures are better positioned to absorb tariff impacts and maintain competitive pricing. The net effect is a more deliberate emphasis on supply chain resilience, scenario-based procurement planning, and collaborative vendor relationships that include risk-sharing mechanisms and forward-looking contingency arrangements.

Granular segmentation analysis linking instrument classes, end-use applications, and distribution pathways to inform product strategy, service models, and channel prioritization

Product segmentation reveals differentiated demand drivers across instrument classes, with unique implications for innovation roadmaps and aftermarket services. Based on Product Type, the landscape is examined across Cell Analysis Instruments, Chromatography Systems, Electrophoresis Systems, PCR Systems, Sequencing Instruments, and Spectroscopy Instruments. Within Cell Analysis Instruments there is a distinct bifurcation between Cell Imaging Systems and Flow Cytometry, each presenting divergent requirements for image analysis software or multiparametric data handling. Chromatography Systems are further specified as Gas Chromatography and Liquid Chromatography, where solvent management, column lifecycle, and detector compatibility influence purchasing decisions and consumable partnerships. Electrophoresis Systems divide into Capillary Electrophoresis and Gel Electrophoresis, with capillary formats gaining attention for automation and miniaturization benefits. PCR Systems are categorized across Conventional PCR, Digital PCR, and Real-Time PCR, reflecting variations in sensitivity, quantitative capability, and regulatory acceptance across clinical and research applications. Sequencing Instruments are discussed in terms of Next-Generation Sequencing and Sanger Sequencing, each retaining distinct value propositions related to throughput, read length, and cost-per-sample trade-offs. Spectroscopy Instruments encompass Infrared Spectroscopy, Mass Spectrometry, Nuclear Magnetic Resonance, and UV-Visible Spectroscopy, a grouping that highlights divergent service, calibration, and consumable support needs.

Application-based segmentation clarifies how end-user needs shape feature prioritization and purchasing cadence. Based on Application, instruments are evaluated across Academic Research, Clinical Diagnostics, Drug Discovery and Development, Environmental Testing, and Food and Beverage Testing. Within Clinical Diagnostics, genetic testing, infectious disease diagnostics, and oncology diagnostics impose stringent validation and traceability requirements, increasing the emphasis on robust documentation and regulatory support from suppliers. Environmental Testing differentiates across air quality testing, soil testing, and water quality testing, with field-deployable instrumentation and ruggedized designs gaining importance for decentralized programs. Food and Beverage Testing divides into nutritional analysis, pathogen detection, and quality assurance, where rapid turnaround and compliance with industry standards are paramount.

The distribution channel perspective illuminates commercial dynamics that influence adoption speed and aftermarket economics. Based on Distribution Channel, market coverage is reviewed through direct sales, distributors and resellers, and online channels. Direct sales relationships tend to dominate for complex, high-value instruments requiring on-site validation, whereas distributors and resellers play a crucial role in extending reach for consumables, accessories, and lower-complexity platforms. Online channels increasingly facilitate smaller transactions, spare part purchases, and software license renewals, introducing new expectations around digital self-service and embedded technical content. Integrating these segmentation lenses provides a granular foundation for designing product roadmaps, support services, and channel strategies that align with diverse end-user needs.

Regional dynamics that explain adoption patterns, regulatory complexity, and support infrastructure requirements across the Americas, EMEA, and Asia-Pacific

Regional dynamics continue to shape adoption timelines, regulatory expectations, and investment priorities across life science instrumentation. The Americas region remains a hub for early-adopting research institutions and clinical laboratories, driving demand for high-throughput platforms and integrated data solutions. Policy dialogues and reimbursement frameworks in this region also place a premium on validated performance and service reliability, encouraging suppliers to reinforce regional support infrastructures and academic partnerships.

Europe, Middle East & Africa present a mosaic of regulatory regimes and purchasing behaviors where harmonized standards drive cross-border procurement within certain subregions while localized needs spur demand for cost-sensitive, ruggedized instrumentation in others. Suppliers often tailor commercial models to accommodate varied procurement cycles and public-sector contracting rules. The Asia-Pacific region is notable for rapid capacity expansion in both research and clinical markets, with significant public and private investment fueling demand for scalable platforms and automation solutions. Here, manufacturers are balancing global product standards with local support capabilities and strategic partnerships to address language, regulatory, and service expectations. Taken together, these regional insights underscore the importance of adaptive go-to-market strategies that combine global R&D investments with regionally optimized commercial and service footprints.

Competitive dynamics driven by hardware incumbents and nimble challengers racing to capture value through software ecosystems, service differentiation, and strategic collaborations

Competitive patterns in the instrumentation arena are being shaped by convergence between legacy hardware leaders and agile entrants that emphasize software, service, and consumables ecosystems. Established manufacturers leverage scale, longstanding validation track records, and broad service networks to defend installed bases, while challengers often compete on speed of innovation, modularity, and digital-first user experiences. Partnerships and non-dilutive collaborations are increasingly common as companies seek to combine complementary strengths-such as hardware engineering with cloud analytics or reagent expertise with field service infrastructure.

Strategic differentiation is frequently found in aftermarket offerings: extended warranties, remote diagnostics, and outcome-focused service contracts improve customer retention and create new recurring revenue streams. Intellectual property around assay compatibility, calibration routines, and data handling algorithms also plays a critical role in shaping competitive moats. In addition, mergers, selective licensing, and OEM agreements continue to reconfigure competitive boundaries, enabling firms to access new application spaces or accelerate geographic expansion while mitigating the time and cost of organic development.

Actionable strategic and tactical recommendations for leaders focused on modular product design, robust service portfolios, resilient supply chains, and channel optimization

Industry leaders should prioritize a set of tactical and strategic moves to solidify market positions and capture value across the instrument lifecycle. First, invest in modular product architectures and open data interfaces to accelerate integration with laboratory information management systems and third-party analytics, thereby lowering switching costs for customers. Second, strengthen service portfolios by combining preventive maintenance, remote diagnostics, and outcome-based contracting to reduce downtime for high-stakes applications and to generate recurring revenue streams. Third, diversify supply chains through multi-sourcing, regional manufacturing partnerships, and component standardization to reduce tariff and logistics exposure while enabling faster response to demand fluctuations.

In parallel, commercial teams should refine channel strategies to balance direct engagement for complex instrument sales with distributor empowerment for consumables and accessories, and enhanced digital channels for aftermarket sales. Investing in regulatory and clinical support capabilities will pay dividends in clinical diagnostics and drug development applications where validation documentation and rapid response to regulatory questions are key purchase drivers. Finally, cultivate partnerships with academic centers and end users to co-develop use-case validations that demonstrate real-world outcomes and accelerate adoption across peer institutions. Implementing these recommendations in an integrated roadmap will align R&D, operations, and commercial functions around prioritized value drivers.

Rigorous blended methodology combining stakeholder interviews, technical synthesis, and scenario analysis to ensure credible and decision-focused insights for instrument stakeholders

The research underpinning this executive summary combines primary stakeholder engagement, secondary literature synthesis, and structured qualitative analysis to ensure robust, decision-relevant findings. Primary inputs included interviews with laboratory directors, procurement officers, and technical managers across research, clinical, and industrial end users, supplemented by conversations with product managers and supply chain leads from instrument vendors. These dialogues informed assessments of procurement criteria, service expectations, and the operational impacts of recent policy changes.

Secondary sources included peer-reviewed literature, regulatory guidance documents, and manufacturer technical specifications to triangulate technical claims and validate performance characteristics. The analytical approach employed thematic coding to identify recurring drivers and inhibitors of adoption, and scenario analysis to explore how tariff and supply chain variables could influence procurement behavior. Quality assurance steps included cross-validation of interview findings against technical documentation and iterative review sessions with domain experts to refine interpretations. This blended methodology supports nuanced insights while preserving transparency about assumptions and data provenance.

Synthesis of strategic imperatives emphasizing modularity, data interoperability, and service-driven partnerships to guide procurement and product development decisions

In conclusion, the life science instrumentation landscape is experiencing a pivotal evolution driven by integration of automation, data-centric workflows, and service-centric commercial models. These forces are reshaping expectations across product development, aftermarket support, and channel strategies, while policy changes and tariff dynamics create new imperatives for supply chain resilience. Stakeholders that align product roadmaps with software interoperability, invest in comprehensive service propositions, and diversify supply chains will be better positioned to navigate near-term disruptions and capture long-term value.

Moving forward, leaders should treat instrument procurement not only as a capital expenditure decision but as a strategic partnership encompassing validation support, data management, and lifecycle care. By embracing modularity, open standards, and collaborative validation approaches, suppliers and purchasers alike can accelerate adoption, reduce operational friction, and improve reproducibility across research and clinical settings. The synthesis presented here provides a practical framework for those decisions, enabling focused action that addresses both technical requirements and commercial realities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven image analysis platforms into high-content microscopy workflows
  • 5.2. Adoption of benchtop next generation sequencers enabling rapid genomic profiling in clinical labs
  • 5.3. Implementation of single-cell multi-omics systems for simultaneous transcriptomic and proteomic analysis
  • 5.4. Development of microfluidic lab-on-a-chip devices for high-throughput drug screening applications
  • 5.5. Expansion of digital PCR technologies for precise quantification of rare genetic variants in diagnostics
  • 5.6. Utilization of automated liquid handling robots for accelerated sample preparation and assay reproducibility
  • 5.7. Launch of CRISPR-based gene editing workstations with integrated delivery and real-time monitoring modules
  • 5.8. Integration of cloud-based data management platforms with real-time remote instrument monitoring capabilities
  • 5.9. Advancement of high-resolution mass spectrometry instruments for enhanced protein structure elucidation
  • 5.10. Implementation of IoT-enabled predictive maintenance systems to minimize instrument downtime and costs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Life Science Instrumentation Market, by Product Type

  • 8.1. Cell Analysis Instruments
    • 8.1.1. Cell Imaging Systems
    • 8.1.2. Flow Cytometry
  • 8.2. Chromatography Systems
    • 8.2.1. Gas Chromatography
    • 8.2.2. Liquid Chromatography
  • 8.3. Electrophoresis Systems
    • 8.3.1. Capillary Electrophoresis
    • 8.3.2. Gel Electrophoresis
  • 8.4. Pcr Systems
    • 8.4.1. Conventional Pcr
    • 8.4.2. Digital Pcr
    • 8.4.3. Real-Time Pcr
  • 8.5. Sequencing Instruments
    • 8.5.1. Next-Generation Sequencing
    • 8.5.2. Sanger Sequencing
  • 8.6. Spectroscopy Instruments
    • 8.6.1. Infrared Spectroscopy
    • 8.6.2. Mass Spectrometry
    • 8.6.3. Nuclear Magnetic Resonance
    • 8.6.4. Uv-Visible Spectroscopy

9. Life Science Instrumentation Market, by Application

  • 9.1. Academic Research
  • 9.2. Clinical Diagnostics
    • 9.2.1. Genetic Testing
    • 9.2.2. Infectious Disease Diagnostics
    • 9.2.3. Oncology Diagnostics
  • 9.3. Drug Discovery And Development
  • 9.4. Environmental Testing
    • 9.4.1. Air Quality Testing
    • 9.4.2. Soil Testing
    • 9.4.3. Water Quality Testing
  • 9.5. Food And Beverage Testing
    • 9.5.1. Nutritional Analysis
    • 9.5.2. Pathogen Detection
    • 9.5.3. Quality Assurance

10. Life Science Instrumentation Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors And Resellers
  • 10.3. Online Channels

11. Life Science Instrumentation Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Life Science Instrumentation Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Life Science Instrumentation Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Bruker Corporation
    • 14.3.2. Eppendorf SE
    • 14.3.3. Hitachi, Ltd.
    • 14.3.4. Horiba, Ltd.
    • 14.3.5. Merck KGaA
    • 14.3.6. PerkinElmer, Inc.
    • 14.3.7. Sartorius AG
    • 14.3.8. Shimadzu Corporation
    • 14.3.9. Thermo Fisher Scientific Inc.
    • 14.3.10. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. LIFE SCIENCE INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. LIFE SCIENCE INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LIFE SCIENCE INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GEL ELECTROPHORESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GEL ELECTROPHORESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GEL ELECTROPHORESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GEL ELECTROPHORESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFRARED SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFRARED SPECTROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFRARED SPECTROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFRARED SPECTROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFRARED SPECTROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFRARED SPECTROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY UV-VISIBLE SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY UV-VISIBLE SPECTROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY UV-VISIBLE SPECTROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY UV-VISIBLE SPECTROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY UV-VISIBLE SPECTROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY UV-VISIBLE SPECTROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY AIR QUALITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY AIR QUALITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY AIR QUALITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY AIR QUALITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY AIR QUALITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY AIR QUALITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SOIL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SOIL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SOIL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SOIL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SOIL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SOIL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY WATER QUALITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY WATER QUALITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY WATER QUALITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY WATER QUALITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY WATER QUALITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY WATER QUALITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY FOOD AND BEVERAGE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PATHOGEN DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PATHOGEN DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PATHOGEN DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PATHOGEN DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS AND RESELLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS AND RESELLERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS AND RESELLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS AND RESELLERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS AND RESELLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS AND RESELLERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY PCR SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SEQUENCING INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY ENVIRONMENTAL TESTING, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS LIFE SCIENCE INSTRUMENTATION MARKET SIZE, BY